Marathon is a privately held company that commits its resources to helping the patients other companies can’t. We are building a portfolio of rare diseases treatments with a focus on late-stage treatments in the CNS therapeutic area. Partnerships with other companies in our industry are critical to our ability to develop new therapies and serve patients.
Marathon’s leadership team has a proven track record of success in developing, commercializing and manufacturing important rare-disease treatments. Our corporate structure and financial independence give us the ability to efficiently bring medicines to under-served and overlooked patients.
We believe we can make a greater difference in patients’ lives by working together. Businesses that are interested in partnering with Marathon can contact us at email@example.com.